Should you buy Kenon Holdings (KEN)?
Updated
Exceptional reported revenue growth of 73% year-over-year and a strong financial health score coexist with an expensive valuation, two recent earnings misses, and negative price momentum — with the analyst target implying 33% upside but upside already deemed exhausted by near-term technicals, the setup favors caution.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
Revenue is growing at 73% year-over-year, a pace that would ordinarily command a premium multiple, yet the valuation is flagged as expensive relative to the sector — suggesting the market has already capitalized a significant portion of the growth outlook into the price. Growth breakdown | If the growth rate sustains and justifies the current multiple, revenue should continue to grow above 40% year-over-year for at least 2 consecutive quarters. | →Stable |
| CounterIf the growth rate is decelerating from its current 73% pace, or if the market re-rates the multiple lower as growth normalizes, the expensive valuation becomes a structural headwind rather than a manageable premium. | ||
The dividend yield has been flagged as potentially unsafe — a yield trap — where the headline payout appears attractive but is not credibly supported by underlying earnings or cash flow, risking a cut that would reprice the stock sharply lower. Catalyst breakdown | If the dividend proves sustainable, the company should generate sufficient earnings coverage to maintain the dividend without a reduction for at least 4 consecutive quarters. | →Stable |
| CounterA strong Piotroski financial health score of 8 out of 9 indicates broad balance-sheet strength; the dividend may be funded through asset sales or non-recurring cash flows that the pure earnings coverage ratio understates. | ||
Price is deeply oversold with RSI at 23 — historically associated with potential reversals — yet the stock remains above its 200-day moving average while on-balance volume is declining, leaving the technical picture mixed and the case for recovery unconfirmed. Momentum breakdown | If technical conditions improve, on-balance volume should turn positive and price should sustain above the 200-day moving average for 4 consecutive weeks. | →Stable |
| CounterFalling on-balance volume despite an elevated price above the long-term average is a distribution signal; the stock may be tracing out a topping pattern rather than setting up a bounce, and the RSI could stay depressed for an extended period. | ||
Revenue is growing at 73% year-over-year, a pace that would ordinarily command a premium multiple, yet the valuation is flagged as expensive relative to the sector — suggesting the market has already capitalized a significant portion of the growth outlook into the price.
→Stable- Expectation
- If the growth rate sustains and justifies the current multiple, revenue should continue to grow above 40% year-over-year for at least 2 consecutive quarters.
CounterIf the growth rate is decelerating from its current 73% pace, or if the market re-rates the multiple lower as growth normalizes, the expensive valuation becomes a structural headwind rather than a manageable premium.
The dividend yield has been flagged as potentially unsafe — a yield trap — where the headline payout appears attractive but is not credibly supported by underlying earnings or cash flow, risking a cut that would reprice the stock sharply lower.
→Stable- Expectation
- If the dividend proves sustainable, the company should generate sufficient earnings coverage to maintain the dividend without a reduction for at least 4 consecutive quarters.
CounterA strong Piotroski financial health score of 8 out of 9 indicates broad balance-sheet strength; the dividend may be funded through asset sales or non-recurring cash flows that the pure earnings coverage ratio understates.
Price is deeply oversold with RSI at 23 — historically associated with potential reversals — yet the stock remains above its 200-day moving average while on-balance volume is declining, leaving the technical picture mixed and the case for recovery unconfirmed.
→Stable- Expectation
- If technical conditions improve, on-balance volume should turn positive and price should sustain above the 200-day moving average for 4 consecutive weeks.
CounterFalling on-balance volume despite an elevated price above the long-term average is a distribution signal; the stock may be tracing out a topping pattern rather than setting up a bounce, and the RSI could stay depressed for an extended period.
▸ Show 1 more pillar▾ Show fewer
The company's Piotroski financial health score of 8 out of 9 reflects broad-based improvement across profitability, leverage, and operating efficiency indicators, providing a quality anchor that partially offsets the weak near-term momentum and earnings execution.
→Stable- Expectation
- If financial health deteriorates meaningfully, the Piotroski score should drop below 6 for 2 consecutive reported periods.
CounterThe two most recent earnings reports both missed estimates, and two of the five consecutive earnings misses carry meaningful surprise deficits — persistent miss trends can erode the Piotroski score over subsequent quarters as profitability metrics weaken.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Revenue is growing at 73% year-over-year, a pace that would ordinarily command a premium multiple, yet the valuation is flagged as expensive relative to the sector — suggesting the market has already capitalized a significant portion of the growth outlook into the price.
Trip ifRevenue growth falls below 30% year-over-year for 2 consecutive reported quarters.
- P2The dividend yield has been flagged as potentially unsafe — a yield trap — where the headline payout appears attractive but is not credibly supported by underlying earnings or cash flow, risking a cut that would reprice the stock sharply lower.
Trip ifCompany announces a dividend reduction greater than 20% from the current payout level.
- P3Price is deeply oversold with RSI at 23 — historically associated with potential reversals — yet the stock remains above its 200-day moving average while on-balance volume is declining, leaving the technical picture mixed and the case for recovery unconfirmed.
Trip ifOn-balance volume turns positive and RSI recovers above 45 for 4 consecutive weeks.
- P4The company's Piotroski financial health score of 8 out of 9 reflects broad-based improvement across profitability, leverage, and operating efficiency indicators, providing a quality anchor that partially offsets the weak near-term momentum and earnings execution.
Trip ifPiotroski F-Score drops below 6 for 2 consecutive reported periods.
How the engine reached this verdict
TrendMatrix's engine output for Kenon Holdings Ltd. (KEN) is SELL_IF_HOLDING with medium conviction, score 5.4/10 at $66.30. The F-path SELL output reflects an overall score of 5.4 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of 0.00 is supplementary context, not the trigger.
The engine's exit framework anchors to a tactical sell band near $66.30, with structural invalidation at $63.11. The asymmetric R:R against a reversal hypothesis is 7.92 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bull side: Strong growth profile. On the bear side: Consecutive earnings misses (2); Expensive valuation; Negative momentum. Active engine warnings: V9 Gate Failed: MOMENTUM:3.0<4.5.
The dominant failed gate is momentum at 3.0 vs threshold 4.5. SELL flips back toward HOLD if momentum recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is INSIDER:OK.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates KEN — 10-dimension breakdown →
Bull case
- ▸Strong growth profile
Bear case
- ▸Consecutive earnings misses (2)
- ▸Expensive valuation
- ▸Negative momentum